About
Dr. Brett Stringer is a Research Fellow at the School of Environment and Science - Bioscience, Griffith University, affiliated with the Institute for Biomedicine and Glycomics. His research focuses on cancer cell biology, neurodegeneration, and glioblastoma treatment, leveraging zebrafish models and advanced imaging techniques like MRI. He explores RNA biology, particularly circular RNAs, and their roles in oncogenesis and neurological disorders. Recent work includes developing nanoparticle-based glioblastoma diagnostics, optimizing drug combinations for cancer therapy, and characterizing novel therapeutic targets.
Dr. Stringer collaborates on interdisciplinary projects addressing glioblastoma plasticity, drug resistance mechanisms, and childhood cancer cell line atlases. He currently supervises five doctoral students investigating neurodegenerative models, neurexin biology, and zebrafish-based ALS/MND research. His work aligns with the UN Sustainable Development Goal 3 (Good Health and Well-Being), emphasizing translational applications for clinical impact.
Key research themes include tumor heterogeneity, cell signaling pathways (e.g., STAT3, ATR), and the interplay between the tumor microenvironment and treatment efficacy. His publications span high-impact journals in oncology, neuroscience, and molecular biology, reflecting contributions to both fundamental and applied biomedical research.
